January 21st 2026

By Ailsa Colquhoun

Alert: Fingolimod Glenmark 0.5 mg Hard Capsules

Glenmark Pharmaceuticals Europe Limited is recalling one batch of Fingolimod Glenmark 0.5 mg Hard Capsules (fingolimod hydrochloride).

The affected batch is:  

The recall is a precautionary measure following out-of-specification stability testing results.  

Dispensary teams are asked to quarantine all remaining stock and return it to your supplier using your supplier’s approved process. Patients should continue to take medicines from these batches as prescribed by your healthcare professional.